contemplated treatment approach that was based on a very limited or poorly validated research.
The methodological problems with the Lord et al. [8] study are itemized in our best-evidence synthesis [1] . At the heart of the methodological flaws are the issues of (1) unbalanced randomization in a very small study population (only 12 subjects receiving the intervention) and (2) the extension of outcomes analysis beyond the time of blinding and validated outcomes assessment (which by design was limited to 3 months or less).
Regarding the unbalanced randomization, this methodological problem was severe and the number of subjects was so small that no statistical adjustment for confounding variables can be made. Lord et al. reported that twice as many subjects in the sham group (33%) had painful facet joints that were not treated. If the authors are correct, one would suspect some continued neck pain in 33% of the sham group on this basis alone. That is before the intervention was even done, the sham group may have had only eight potential subjects who could report complete neck pain relief (the success criterion) with four cases having untreated neck problems necessarily falling within the failed treatment category. To have a ''controlled'' study with only a small number of subjects, randomization not only should be performed, it needs to be successful in providing similar populations of patients in the treatment and controlled groups.
Along the same line of unbalanced randomization, 83% of the sham group had litigation related to the neck pain syndrome being treated (vs. 33% of the RF group). Drs. Dreyfuss and Baker cite the work of the senior author of the Lord et al. [8] and a study of Sapir and Gorup [9] , to contend that litigation is clinically irrelevant in the context of chronic whiplash disorders. To most active clinicians, this proposition does not pass ''the chuckle test,'' nor does it comport with the literature in general [2, 3, 6] . In fact, the study by Sapir and Gorup cited by Drs. Baker and Dreyfuss actually reported worse outcomes in active litigation subjects undergoing RF neurotomy (at 2 week 15% more nonlitigation subjects achieved [70% pain reduction after RF, and at 1 year a higher pain VAS of 4.0 in the litigation group versus 2.9 (non-litigation), P = 0.05).
More telling is the study by Dr. Dreyfuss himself, on RF for facet pain [4] . In that study Dr. Dreyfuss excluded subjects with ''compensable disability or work injury, [or] ongoing litigation'' because these factors were ''comorbid or psychosocial factors…likely to confound the results.'' We completely agree with Dr. Dreyfuss' own assessment: compensation disputes and litigation are very likely to confound a study's results. So when the Lord et al. study reported far more of the sham group had active litigation issues there is little confidence that outcomes differences in favor of the RF procedure can be attributable to the intervention alone.
Next, there is the issue of loss of blinding due to documented sensory changes in nearly half the RF group (none in the sham group) soon after the procedure and additional selective un-blinding at 3 months. Our group had, again, little confidence that either the evaluating surgeon or the subjects were actually blinded to which treatment was received in these subjects and expect some reporting bias is possible for that reason.
Finally, after the blinding protocol had been broken at 3 months, subjects were then followed by the un-validated (and likely inaccurate) method of being directed to call back when their pain exceeded 50% of their pre-procedure intensity. Lord et al. counted any subject they did not hear from as a success! This assumption is, charitably stated, dubious. Therefore, although a Kaplan-Meier and Cox Proportional Hazard analysis may have been reasonable if the subjects had been followed with standard metrics every month or so, this was not the case. The most valid data appear to be that collected before the patient-initiated ''call back assessment'' method was begun (3 months). For those few data points the Fisher Exact test is an appropriately applied analysis for small subject studies. Clearly, there was no statistical difference in outcomes at 3 weeks or at 3 months-despite the randomization imbalances strongly favoring the RF group.
The Govind et al. [5] study, again by the same research group, on RF neurotomy for suspected cervicogenic headache was also felt to be scientifically inadmissible by the Task Force. While Govind et al., do report ''extraordinary'' results, they unfortunately also report less than extraordinary methods: this was an unblinded, uncontrolled, nonrandomized case-series report. No independent examiner, nor standard pain metrics, nor functional questionnaires were used to assess outcome. This case-series was promptly criticized for these methodological flaws in the same journal [7] . Clearly, exploratory studies such as Govind et al. are important and are needed to direct more definitive clinical research. They are, however, the least substantial of all forms of clinical evidence, and a poor basis for advocating general clinical application of invasive treatments.
Both Dr. Dreyfuss and Dr. Baker are careful clinicians and scientific thinkers, whom we respect immensely. In fact we expected, at the onset of our best-evidence synthesis, to find much more substantial evidence supporting RF in this area. We, like Drs. Dreyfuss and Baker, believed that RF neurotomy might have had good data supporting treatment for neck pain in appropriately selected patients. However, we did not find this and, frankly, if these two highly-flawed papers are the ''best evidence'' for the use of RF neurotomy in neck pain syndromes, this is sad news indeed-and well out of step with efforts to increase standards for evidence-based clinical care. After careful review of this area of treatment, it is clear that the most basic studies still need to be performed. If these are highly effective treatments, it should be easily proven in a properly designed trial, as we outlined in our research recommendations [1] , and testing the hypothesis should be a priority for those interested in this type of intervention.
